Last reviewed · How we verify

NCT07184177

Validation of Heart Rate Monitors in Overweight and Obese Young Adults

Not yet recruiting Last updated 19 September 2025
What this trial tests

trial in Obesity &Amp; Overweight in 52 participants. Not yet recruiting.

Timeline
19 January 2026
Primary endpoint
5 June 2026
4 December 2026

Quick facts

Lead sponsorUniversidad Autonoma de Baja California
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment52
Start date19 January 2026
Primary completion5 June 2026
Estimated completion4 December 2026

Conditions studied

Sponsor

Universidad Autonoma de Baja California — full company profile →

Who can join

Adults 18 to 25, any sex, with Obesity &Amp; Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overweight and obesity are defined as an excessive accumulation of body fat that affects health. According to data from the World Health Organization (WHO), in 2022, there were 2.5 billion adults aged 18 years and older who were overweight, of whom 890 million were obese. In other words, 43% of adults aged 18 years and older were overweight, and 16% of them were obese. Overweight and obesity are key risk factors for various chronic diseases such as diabetes, hypertension, cardiovascular disease, and even some types of cancer. There is evidence that mortality from cardiovascular disease, and the incidence of cancer and diabetes, varies according to the amount of physical activity. In the context of high levels of sedentary time, higher levels of moderate to vigorous physical activity are recommended. There are various ways to treat overweight and obesity, the main ones usually being lifestyle changes, such as following a healthy diet and regular physical activity, as well as following pharmacological treatments. In this project, the focus will be on the fat metabolism generated during moderate physical activity. There are physical activity interventions aimed at increasing fat metabolism that may potentially reduce the symptoms of metabolic diseases such as obesity and type 2 diabetes. For this purpose, it is important to understand the factors that increase or decrease fat oxidation. Factors such as exercise intensity and duration are important to understand when determining maximum fat oxidation (FatMax). The aim is to develop comprehensive research that will generate knowledge and evidence on health issues with social impact through the evaluation of commercial technologies and innovative actions that promote the prevention, treatment, and resolution of national health problems such as obesity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obesity &Amp; Overweight

Currently open trials in the same condition.

Other Universidad Autonoma de Baja California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07184177.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing